Interferon-free HCV-1 regimen scored high in patients co-infected with HIV

From Internal Medicine News, 24 July 2014: MELBOURNE – A regimen of ABT-450 coformulated with ritonavir, ombitasvir, and dasabuvir, plus ribavirin, resulted in high rates of sustained virologic response in hepatitis C patients co-infected with HIV. Further, the treatment approach did not have a negative effect on HIV viral load. Data from the open-label study, Continue reading Interferon-free HCV-1 regimen scored high in patients co-infected with HIV

Sofosbuvir achieves sustained response in patients with hepatitis C and HIV

From Skin and Allergy News, 21 July 2014: Treatment with the interferon-free oral nucleotide analog sofosbuvir plus ribavirin achieved high rates of sustained virologic response in patients with HIV coinfected with hepatitis C, according to data from an open-label phase III study. Researchers observed an 82% response rate among treatment-naive patients coinfected with hepatitis C Continue reading Sofosbuvir achieves sustained response in patients with hepatitis C and HIV